Infectious Diseases Unit, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
Cystic Fibrosis Center, Azienda Ospedaliero-Universitaria di Verona, P.le Stefani 1, 37126, Verona, Italy.
Ital J Pediatr. 2018 Jun 28;44(1):72. doi: 10.1186/s13052-018-0512-y.
Cystic Fibrosis (CF) Centers are involved in the decisions regarding the eligibility of CF patients with end-stage lung disease and timing for inclusion on waiting lists (WL) for lung transplantation (LT). There are currently no data on the mortality rates of Italian CF patients on WL and during the first year after LT and we aimed to assess these outcomes by surveying the CF Centers.
A survey was sent to Italian CF Centers which were requested to report the age at which all CF subjects included on the WL between 2010 and 2014 were included on the list, admitted to either standard or urgent LT, or had died either while on the WL or within the first 3 and 12 months after LT. All outcomes were recorded by December 31, 2015.
Two hundred fifty-nine CF subjects were included on the WL during the 5-year study period. The mortality rate during the WL was 19.3% and was not associated with sex, age at inclusion on the WL or standard or urgent access to LT. 159 (61.4%) subjects underwent LT, 46 (28.9%) with urgent procedure. Deaths within the first 3 and 12 months after LT were significantly more prevalent in individuals who underwent urgent LT compared to those with standard LT (p < 0.01).
The mortality of Italian CF patients, included in our survey, was about twice that reported by the National Transplant Center for all LT indications, including CF, during the same time period and despite the introduction of urgent LT. The latter was associated with an unfavorable early outcome compared to standard LT.
囊性纤维化 (CF) 中心参与了对终末期肺病的 CF 患者的资格和肺移植 (LT) 等候名单 (WL) 纳入时间的决策。目前尚无意大利 CF 患者 WL 上和 LT 后第一年的死亡率数据,我们旨在通过调查 CF 中心来评估这些结果。
向意大利 CF 中心发送了一份调查,要求其报告 2010 年至 2014 年期间所有纳入 WL 的 CF 患者的年龄,这些患者被纳入标准或紧急 LT,或在 WL 上或 LT 后 3 个月和 12 个月内死亡。所有结果均记录至 2015 年 12 月 31 日。
在 5 年的研究期间,有 259 名 CF 患者被纳入 WL。WL 期间的死亡率为 19.3%,与性别、纳入 WL 的年龄或标准或紧急 LT 途径无关。159 名 (61.4%) 患者接受了 LT,46 名 (28.9%) 接受了紧急手术。LT 后 3 个月和 12 个月内死亡的患者明显多于接受紧急 LT 的患者 (p<0.01)。
在我们的调查中,包括在意大利 CF 患者中的死亡率是同期全国移植中心报告的所有 LT 适应证(包括 CF)的两倍,尽管引入了紧急 LT。与标准 LT 相比,后者与不利的早期结果相关。